JBF Capital’s Coya Therapeutics COYA Stock Holding History

JBF Capital’s Portfolio COYA Stock Details COYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$585K	Hold	100,006	–	–	0.08%	53
2026 Q1	$394K	Hold	100,006	–	–	0.06%	71
2025 Q4	$580K	Buy	+100,006	New	+$608K	0.08%	45

Other funds holding COYA

DCM

DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

JBF Capital's COYA Position: Q2 2026 in Review

JBF Capital held its Coya Therapeutics (COYA) position steady in Q2 2026 at 100,006 shares worth $585K. The position accounts for 0.08% of the portfolio, ranked #53.

JBF Capital first reported a position in COYA in Q4 2025 and has held it in 3 quarters since. 54 funds tracked by Wall St. Rank hold COYA as of Q2 2026.

JBF Capital held 100,006 shares of Coya Therapeutics worth $585K as of Q2 2026.
JBF Capital left its Coya Therapeutics share count unchanged in Q2 2026.
Coya Therapeutics made up 0.08% of JBF Capital's portfolio in Q2 2026, its #53 holding.
JBF Capital first reported a position in Coya Therapeutics in Q4 2025 and has held it in 3 quarters since.
54 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2026.

Based on JBF Capital's 13F filing for Q2 2026, filed 13 Aug 2026.